Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $95,325 | 4 | 99.9% |
| Food and Beverage | $119.60 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma Global Development | $94,800 | 2 | $0 (2019) |
| Change Healthcare Technologies, LLC | $525.00 | 2 | $0 (2022) |
| Medtronic, Inc. | $119.60 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $119.60 | 1 | Medtronic, Inc. ($119.60) |
| 2022 | $525.00 | 2 | Change Healthcare Technologies, LLC ($525.00) |
| 2019 | $61,800 | 1 | Astellas Pharma Global Development ($61,800) |
| 2018 | $33,000 | 1 | Astellas Pharma Global Development ($33,000) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/04/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $119.60 | General |
| Category: Stents | ||||||
| 08/16/2022 | Change Healthcare Technologies, LLC | Change Healthcare Cardiology (Device) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: CARDIOLOGY | ||||||
| 02/08/2022 | Change Healthcare Technologies, LLC | Change Healthcare Cardiology (Device) | Consulting Fee | Cash or cash equivalent | $225.00 | General |
| Category: CARDIOLOGY | ||||||
| 07/25/2019 | Astellas Pharma Global Development | MYRBETRIQ (Drug) | Consulting Fee | Cash or cash equivalent | $61,800.00 | General |
| Category: UROLOGY | ||||||
| 12/14/2018 | Astellas Pharma Global Development | MYRBETRIQ (Drug) | Consulting Fee | Cash or cash equivalent | $33,000.00 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,331 | 4,771 | $1.0M | $195,582 |
| 2022 | 17 | 2,695 | 3,807 | $924,270 | $184,120 |
| 2021 | 17 | 3,349 | 4,986 | $1.0M | $213,057 |
| 2020 | 19 | 3,488 | 5,106 | $997,820 | $193,855 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 352 | 357 | $307,020 | $56,489 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 341 | 476 | $97,580 | $46,457 | 47.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 496 | 523 | $371,330 | $28,608 | 7.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,156 | 2,195 | $87,800 | $14,325 | 16.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 75 | 164 | $22,960 | $11,016 | 48.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 533 | 643 | $35,365 | $7,258 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $17,010 | $6,663 | 39.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 41 | $15,785 | $5,888 | 37.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 54 | $14,040 | $5,701 | 40.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 54 | $10,800 | $5,390 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 40 | $5,600 | $2,505 | 44.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 29 | 29 | $14,500 | $2,485 | 17.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 19 | 19 | $4,750 | $1,009 | 21.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 25 | 28 | $5,880 | $582.40 | 9.9% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 25 | 25 | $1,250 | $539.75 | 43.2% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 28 | 28 | $5,180 | $399.06 | 7.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 20 | 20 | $3,700 | $214.68 | 5.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 21 | 21 | $2,730 | $51.00 | 1.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 295 | 305 | $262,300 | $49,975 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 315 | 469 | $96,145 | $44,893 | 46.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 457 | 489 | $347,190 | $27,803 | 8.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 76 | 77 | $29,645 | $12,744 | 43.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 746 | 1,438 | $57,520 | $9,396 | 16.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 57 | 101 | $20,325 | $8,628 | 42.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 85 | 143 | $20,020 | $8,618 | 43.0% |
About Dr. Brian Barr, MD
Dr. Brian Barr, MD is a Cardiovascular Disease healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1306007398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Barr, MD has received a total of $95,445 in payments from pharmaceutical and medical device companies, with $119.60 received in 2024. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($95,325).
As a Medicare-enrolled provider, Barr has provided services to 12,863 Medicare beneficiaries, totaling 18,670 services with total Medicare billing of $786,613. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Baltimore, MD
- Active Since 06/23/2008
- Last Updated 02/27/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1306007398
Products in Payments
- MYRBETRIQ (Drug) $94,800
- Change Healthcare Cardiology (Device) $525.00
- ONYX FRONTIER (Device) $119.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Baltimore
Dr. Navin Kapur, M.d, M.D
Cardiovascular Disease — Payments: $1.8M
Sanjay Rajagopalan, Md, MD
Cardiovascular Disease — Payments: $572,017
Dr. Michael Blaha, M.d., Mph, M.D., MPH
Cardiovascular Disease — Payments: $569,288
Hugh Calkins, M.d, M.D
Cardiovascular Disease — Payments: $387,473
Dr. Charles Cummings, M.d, M.D
Cardiovascular Disease — Payments: $337,057
Dr. Charles Love, M.d, M.D
Cardiovascular Disease — Payments: $327,551